Tyrosine Kinase Inhibition in Acute Myeloid Leukemia

Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2012.754889
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

A Tyrosine Kinase-Stat5-miR21-Pdcd4 Regulatory Axis in Chronic and Acute Myeloid Leukemia Cells

Oncotarget
Oncology
2017English

Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia

Oncology and Therapy
Oncology
2019English

Tyrosine Kinase Inhibition Increases the Cell Surface Localization of FLT3-ITD and Enhances FLT3-directed Immunotherapy of Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

Transcriptional Silencing of McL-1 Through Cyclin-Dependent Kinase Inhibition in Acute Myeloid Leukemia

Frontiers in Oncology
Cancer ResearchOncology
2019English

Tyrosine Kinase Inhibition: A Therapeutic Target for the Management of Chronic-Phase Chronic Myeloid Leukemia

Expert Review of Anticancer Therapy
OncologyPharmacology
2013English

Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Future Perspectives of Tyrosine Kinase Inhibitors Discontinuation in Chronic Myeloid Leukemia

Chemotherapy: Open Access
2017English

Complications of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia - Chronic Phase

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2019English

Managing Chronic Myeloid Leukemia Patients Intolerant to Tyrosine Kinase Inhibitor Therapy

Blood Cancer Journal
OncologyHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy